Medical Retina and Macular Diseases focuses on disorders affecting the retina, macula, and choroid that are primarily managed through medical, pharmacological, or non-surgical approaches. Topics include age-related macular degeneration, diabetic retinal disease, vascular disorders, macular conditions, retinal degeneration, multimodal imaging, and emerging retinal therapies.
Abstract Scope and Participation
Abstracts may address retinal disease mechanisms, imaging, diagnostics, pharmacological treatments, intravitreal therapies, clinical trials, biomarkers, disease progression, and treatment outcomes. Retina specialists, ophthalmologists, researchers, imaging experts, vision scientists, and professionals involved in retinal therapeutics are invited to contribute.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom